Sorafenib (Nexavar® ) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia
Safaian, N.N, Czibere, A, Bruns, I, Fenk, R, Reinecke, P, Dienst, A, Haas, R, Kobbe, G
Published in Leukemia research (01.02.2009)
Published in Leukemia research (01.02.2009)
Get full text
Journal Article
Bendamustine in patients with relapsed or refractory multiple myeloma
Michael, M, Bruns, I, Bölke, E, Zohren, F, Czibere, A, Safaian, N N, Neumann, F, Haas, R, Kobbe, G, Fenk, Roland
Published in European journal of medical research (29.01.2010)
Published in European journal of medical research (29.01.2010)
Get full text
Journal Article